Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consistency of Immunogenicity of GSK's Malaria Vaccine (RTS,S/AS01) Lots in Children
NCT01323972Phase 3Completed
- Sponsor
- GSK
- Start
- May 2011
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of RTS,S in Plasmodium falciparum malaria, sponsored by GSK. Started May 2011; status: completed.
02
Drugs
RTS,S
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01323972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323972.